| 1 |
Hernandez W, Gamazon ER, Smithberger E, et al. Novel genetic predictors of venous thromboembolism risk in African Americans[J]. Blood, 2016, 127(15):1923-1929.
|
| 2 |
Bokshan SL, DeFroda SF, Panarello NM, et al. Risk factors for deep vein thrombosis or pulmonary embolus following anterior cruciate ligament reconstruction[J]. Orthop J Sports Med, 2018, 6(6):2325967118781328.doi: 10.1177/2325967118781328.
|
| 3 |
Xiang Q, Zhang HX, Wang Z, et al. The predictive value of circulating microRNAs for venous thromboembolism diagnosis:A systematic review and diagnostic meta-analysis[J]. Thromb Res, 2019, 181:127-134.
|
| 4 |
Turetz M, Sideris AT, Friedman OA, et al. Epidemiology, pathophysiology, and natural history of pulmonary embolism[J]. Semin Intervent Radiol, 2018, 35(2):92-98.
|
| 5 |
Sun LL, Xiao L, Du XL, et al. MiR-205 promotes endothelial progenitor cell angiogenesis and deep vein thrombosis recanalization and resolution by targeting PTEN to regulate Akt/autophagy pathway and MMP2 expression[J]. J Cell Mol Med, 2019, 23(12):8493-8504.
|
| 6 |
Lamsam L, Sussman ES, Iyer AK, et al. Intracranial hemorrhage in deep vein thrombosis/pulmonary embolus patients without atrial fibrillation: direct oral anticoagulants versus warfarin[J]. Stroke, 2018, 49(8):1866-1871.
|
| 7 |
Grosse SD, Nelson RE, Nyarko KA, et al. The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs[J]. Thromb Res, 2016, 137:3-10.
|
| 8 |
Li WD, Li XQ. Endothelial progenitor cells accelerate the resolution of deep vein thrombosis[J]. Vascul Pharmacol, 2016, 83:10-16.
|
| 9 |
孙莉莉, 李文东, 李晓强, 等. 内皮祖细胞在深静脉血栓机化再通中的作用[J]. 中华普通外科杂志, 2017, 32(12):1079-1082.
|
| 10 |
Li WD, Zhou DM, Sun LL, et al. LncRNA WTAPP1 promotes migration and angiogenesis of endothelial progenitor cells via MMP1 through MicroRNA 3120 and Akt/PI3K/Autophagy pathways[J]. Stem Cells, 2018, 36(12):1863-1874.
|
| 11 |
Sun LL, Lei FR, Jiang XD, et al. LncRNA GUSBP5-AS promotes EPC migration and angiogenesis and deep vein thrombosis resolution by regulating FGF2 and MMP2/9 through the miR-223-3p/FOXO1/Akt pathway[J]. Aging, 2020, 12(5):4506-4526.
|
| 12 |
李文东, 李晓强, 肖伦. 下肢深静脉血栓治疗现状与趋势[J]. 中国实用外科杂志, 2017, 37(12):1354-1358.
|
| 13 |
中华医学会外科学分会血管外科学组. 深静脉血栓形成的诊断和治疗指南(第三版)[J]. 中华普通外科杂志, 2017, 32(9):807-812.
|
| 14 |
李文东, 李晓强, 钱爱民, 等. 下肢深静脉血栓形成治疗进展[J]. 中国实用外科杂志, 2014, 34(12):1190-1193.
|
| 15 |
Diaz JA, Ramacciotti E, Wakefield TW. Do galectins play a role in venous thrombosis? a review[J]. Thromb Res, 2010, 125(5):373-376.
|
| 16 |
Heit JA, Cohen AT, Anderson FA. Estimated annual number of incident and recurrent, non-fatal and fatal venous thromboembolism (VTE) events in the US[J]. Blood, 2005, 106(11):267A.
|
| 17 |
Giordano NJ, Jansson PS, Young MN, et al. Epidemiology, pathophysiology, stratification, and natural history of pulmonary embolism[J]. Tech Vasc Interv Radiol, 2017, 20(3):135-140.
|
| 18 |
Boon G, Van Dam LF, Klok FA, et al. Management and treatment of deep vein thrombosis in special populations[J]. Expert Rev Hematol, 2018:11(9):685-695.
|
| 19 |
Piazza G, Goldhaber SZ. Acute pulmonary embolism: part I: epidemiology and diagnosis[J]. Circulation, 2006, 114(2):e28-32.
|
| 20 |
Zhou DM, Sun LL, Zhu J, et al. MiR-9 enhancs angiogenesis of endothelial progenitor cell to facilitate thrombi recanalization via targeting TRPM7 through PI3K/Akt /autophagy pathway[J]. J Cell Mol Med, 2020, 24(8):4624-4632.
|
| 21 |
Cushman M. Epidemiology and risk factors for venous thrombosis[J]. Semin Hematol, 2007, 44(2):62-69.
|
| 22 |
Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study[J]. Arch Intern Med, 2000, 160(6):761-768.
|
| 23 |
Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis[J]. Ann Intern Med, 1996, 125(1):1-7.
|
| 24 |
Sun J, Zhang Z, Ma T, et al. Endothelial progenitor cell-derived exosomes, loaded with miR-126, promoted deep vein thrombosis resolution and recanalization[J]. Stem Cell Res Ther, 2018, 9(1):223. doi: 10.1186/s13287-018-0952-8.
|
| 25 |
Santo SD, Tepper OM, von Ballmoos MW, et al. Cell-based therapy facilitates venous thrombus resolution[J]. Thromb Haemost, 2009, 101(03):460-464.
|
| 26 |
Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis[J]. Science, 1997, 275(5302):964-966.
|
| 27 |
Modarai B, Burnand KG, Sawyer B, et al. Endothelial progenitor cells are recruited into resolving venous thrombi[J]. Circulation, 2005, 111(20):2645-2653.
|
| 28 |
Modarai B, Burnand KG, Humphries J, et al. The role of neovascularisation in the resolution of venous thrombus[J]. Thromb Haemost, 2005, 93(5):801-809.
|
| 29 |
Miller-Kasprzak E, Jagodzinski PP. Endothelial progenitor cells as a new agent contributing to vascular repair[J]. Arch Immunol Ther Exp (Warsz), 2007, 55(4):247-259.
|
| 30 |
Werner N, Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells:limitations for therapy?[J]. Arterioscler Thromb Vasc Biol, 2006, 26(2):257-266.
|
| 31 |
Al Mheid I, Hayek SS, Ko YA, et al. Age and human regenerative capacity impact of cardiovascular risk factors[J]. Circ Res, 2016, 119(7):801-809.
|
| 32 |
Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk[J]. N Engl J Med, 2003, 348(7):593-600.
|
| 33 |
Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function[J]. Nat Rev Genet, 2016, 17(1):47-62.
|
| 34 |
Winter J, Jung S, Keller S, et al. Many roads to maturity:microRNA biogenesis pathways and their regulation[J]. Nat Cell Biol, 2009, 11(3):228-234.
|
| 35 |
Wang X, Sundquist K, Elf JL, et al. Diagnostic potential of plasma microRNA signatures in patients with deep-vein thrombosis[J]. Thromb Haemost, 2016, 116(2):328-336.
|
| 36 |
Teruel R, Corral J, Perez-Andreu V, et al. Potential role of miRNAs in developmental haemostasis[J]. PLoS One, 2011, 6(3):e17648.doi: 10.1371/journal.pone.0017648.
|
| 37 |
Nourse J, Braun J, Lackner K, et al. Large-scale identification of functional microRNA targeting reveals cooperative regulation of the hemostatic system[J]. J Thromb Haemost, 2018, 16(11):2233-2245.
|
| 38 |
Xiong G, Jiang X, Song T. The overexpression of lncRNA H19 as a diagnostic marker for coronary artery disease[J]. Rev Assoc Med Bras (1992), 2019, 65(2):110-117.
|
| 39 |
Wu D, Zhou Y, Fan Y, et al. LncRNA CAIF was downregulated in end-stage cardiomyopathy and is a promising diagnostic and prognostic marker for this disease[J]. Biomarkers, 2019, 24(8):735-738.
|
| 40 |
Calin GA , Dumitru CD, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia[J]. Proc Natl Acad Sci U S A, 2002, 99(24):15524-15529.
|
| 41 |
Du B, Wang J, Zang S, et al. Long non-coding RNA MALAT1 suppresses the proliferation and migration of endothelial progenitor cells in deep vein thrombosis by regulating the Wnt/beta-catenin pathway[J]. Exp Ther Med, 2020, 20(4):3138-3146.
|
| 42 |
Qian AM, Li WD, Kong LS, et al. Long noncoding RNA expression profile of endothelial progenitor cells from deep vein thrombosis patients identified by microarray analysis[J]. Int J Clin Exp Pathol, 2016, 9(12):12275-12286.
|
| 43 |
Lou ZK, Zhu JW, Li X, et al. LncRNA Sirt1-AS upregulates Sirt1 to attenuate aging related deep venous thrombosis[J]. Aging, 2021, 13(5):6918-6935.
|
| 44 |
Wang K, Liu F, Zhou LY, et al. The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489[J]. Circ Res, 2014, 114(9):1377-1388.
|
| 45 |
Zeng R, Song XJ, Liu CW, et al. LncRNA ANRIL promotes angiogenesis and thrombosis by modulating microRNA-99a and microRNA-449a in the autophagy pathway[J]. Am J Transl Res, 2019, 11(12):7441-7448.
|
| 46 |
Jha PK, Vijay A, Prabhakar A, et al. Transcriptome profiling reveals the endogenous sponging role of LINC00659 and UST-AS1 in high altitude induced thrombosis[J]. Thromb Haemost, 2021, 121(11):1497-1511.
|
| 47 |
Gu S, Li G, Zhang X, et al. Aberrant expression of long noncoding RNAs in chronic thromboembolic pulmonary hypertension[J]. Mol Med Rep, 2015, 11(4):2631-2643.
|
| 48 |
Yang K, Li W, Duan W, et al. Resveratrol attenuates pulmonary embolism associated cardiac injury by suppressing activation of the inflammasome via the MALAT1miR223p signaling pathway[J]. Int J Mol Med, 2019, 44(6):2311-2320.
|
| 49 |
孙莉莉, 李文东, 李晓强, 等. 内皮祖细胞在血管新生及相关疾病中的作用[J]. 中国普通外科杂志, 2020, 29(6):759-764.
|
| 50 |
Kong L, Hu N, Du X, et al. Upregulation of miR-483-3p contributes to endothelial progenitor cells dysfunction in deep vein thrombosis patients via SRF[J]. J Transl Med, 2016, 14:23. doi: 10.1186/s12967-016-0775-2.
|
| 51 |
Zhou DM, Sun LL, Zhu J, et al. MiR-9 promotes angiogenesis of endothelial progenitor cell to facilitate thrombi recanalization via targeting TRPM7 through PI3K/Akt/autophagy pathway[J]. J Cell Mol Med, 2020, 24(8):4624-4632.
|
| 52 |
Du X, Hong L, Sun L, et al. miR-21 induces endothelial progenitor cells proliferation and angiogenesis via targeting FASLG and is a potential prognostic marker in deep venous thrombosis[J]. J Transl Med, 2019, 17(1):270.doi: 10.1186/s12967-019-2015-z.
|
| 53 |
Wang W, Zhu X, Du X, et al. MiR-150 promotes angiogensis and proliferation of endothelial progenitor cells in deep venous thrombosis by targeting SRCIN1[J]. Microvasc Res, 2019, 123:35-41.
|
| 54 |
Meng Q, Wang W, Yu X, et al. Upregulation of MicroRNA-126 contributes to endothelial progenitor cell function in deep vein thrombosis via its target PIK3R2[J]. J Cell Biochem, 2015, 116(8): 1613-1623.
|
| 55 |
Mo J, Zhang D, Yang R. MicroRNA-195 regulates proliferation, migration, angiogenesis and autophagy of endothelial progenitor cells by targeting GABARAPL1[J]. Biosci Rep, 2016, 36(5):e00396. doi: 10.1042/BSR20160139.
|
| 56 |
Jin J, Wang C, Ouyang Y, et al. Elevated miR-195-5p expression in deep vein thrombosis and mechanism of action in the regulation of vascular endothelial cell physiology[J]. Exp Ther Med, 2019, 18(6): 4617-4624.
|
| 57 |
Jin QQ, Sun JH, Du QX, et al. Integrating microRNA and messenger RNA expression profiles in a rat model of deep vein thrombosis[J]. Int J Mol Med, 2017, 40(4):1019-1028.
|
| 58 |
Lu Z, Wang S, Zhu X, et al. Resveratrol induces endothelial progenitor cells angiogenesis via MiR-542-3p by targeting angiopoietin-2 and involves in recanalization of venous thrombosis[J]. Med Sci Monit, 2019, 25:7675-7683.
|
| 59 |
Ni HZ, Liu Z, Sun LL, et al. Metformin inhibits angiogenesis of endothelial progenitor cells via miR-221-mediated p27 expression and autophagy[J]. Future Med Chem, 2019, 11(17):2263-2272.
|